| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6280148 | Neuroscience Letters | 2016 | 6 Pages | 
Abstract
												Our results demonstrated that the subcutaneous administration of DPDPE inhibited the mechanical and thermal allodynia as well as the thermal hyperalgesia induced by diabetes in a dose-dependent manner. Moreover, while the antinociceptive effects produced by a low dose of DPDPE were enhanced by CORM-2 or CoPP co-treatments, the inhibitory effects produced by a high dose of DPDPE were completely reversed by the administration of an HO-1 inhibitor, SnPP, indicating the involvement of HO-1 in the antinociceptive effects produced by this DOR agonist during diabetic neuropathic pain in mice. In conclusion, this study shows that the administration of CORM-2 or CoPP combined with a DOR agonist could be an interesting strategy for the treatment of painful diabetic neuropathy.
											Keywords
												
											Related Topics
												
													Life Sciences
													Neuroscience
													Neuroscience (General)
												
											Authors
												SÃlvia Castany, Mireia Carcolé, Sergi Leánez, Olga Pol, 
											